FG 001
Alternative Names: FG-001; FG001 sodium; ICG-Glu-Glu-AE105Latest Information Update: 10 Jul 2025
At a glance
- Originator FluoGuide
- Class Diagnostic agents; Imaging agents
- Mechanism of Action Diagnostic imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Glioblastoma; Glioma; Head and neck cancer; Meningioma; Non-small cell lung cancer; Squamous cell cancer
- No development reported Pancreatic cancer
Most Recent Events
- 03 Jul 2025 FluoGuide announces intention to file IND application with the US FDA in USA for Glioblastoma in second half of 2025
- 03 Jul 2025 FluoGuide announces intention to file NDA application with the US FDA in USA for Glioblastoma
- 03 Jul 2025 FluoGuide announces intention to plan pre-IND meeting request with FDA for Glioblastoma in July 2025